Tumor Susceptibility Gene 101 (TSG101) Peptide
Quick Overview for Tumor Susceptibility Gene 101 (TSG101) Peptide (ABIN8115061)
Target
Source
Application
-
-
Purpose
- TSG101 Peptide
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
This is a synthetic peptide designed for use in combination with anti-TSG101 antibody ( ARP37911_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- TSG101 (Tumor Susceptibility Gene 101 (TSG101))
-
Background
-
Background Information: TSG101 has a direct role in the control of growth and differentiation in primary epithelial cells. It is required for normal cell function of embryonic and adult tissues but that this gene is not a tumor suppressor for sporadic forms of breast cancer.
Alternative Symbols: CC2, AI255943
-
Molecular Weight
- 43kDa
-
Gene ID
- 22088
-
NCBI Accession
- NP_068684
-
UniProt
- Q61187
Target
-